Clinical application of amantadine, an NMDA antagonist, for neuropathic pain

Journal of Anesthesia

Volumn 15, Issue 3, 2001, Pages 179-181

  Fukui, S ^a   Komoda, Y ^a   Nosaka, S ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Amantadine; Neuropathic pain; NMDA receptor antagonist

Indexed keywords

AMANTADINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AGED; ALLODYNIA; ANALGESIA; ARTICLE; BRACHIAL PLEXUS NEUROPATHY; CLINICAL ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DROWSINESS; DYSKINESIA; EXCITATION; FEMALE; HAIR LOSS; HALLUCINATION; HUMAN; INVOLUNTARY MOVEMENT; IRRITABILITY; MALE; NERVE BLOCK; NEUROPATHY; PAIN; PAIN ASSESSMENT; PHANTOM PAIN; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; RATING SCALE; SIDE EFFECT; THORACOTOMY; TREATMENT FAILURE; TREATMENT OUTCOME; VERTIGO; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 0034801956     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005400170025     Document Type: Article

References (21)

1. Drug therapy of neuropathic pain
2. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: Implications for the treatment of post-injury pain hypersensitivity states
3. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence
4. Response of chronic neuropathic pain syndromes to ketamine. A preliminary study
5. Beneficial effects of ketamine in chronic pain state with allodynia, possibly due to central sensitization
6. Relief of post-herpetic neuralgia with the N-methyl-D-asparatic acid receptor antagonist ketamine: Double-blind, crossover, comparison with morphine and placebo
7. Continuous subcutaneous administration of the N-methyl-D-asparatic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia
8. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain
9. The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input
10. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride
11. Ketamine, an NMDA receptor antagonist, supresses spatial and temporal properties of burn-induced secodary hyperalgesia in man: A double-blind, cross-over comparison with morphine and placebo
12. Central dysesthesia pain after spinal cord injury is dependent on N-methyl-D-aspartate receptor activation
13. Ketamine hydrochloride in the treatment of phantom limb pain
14. The N-methyl-D-asparate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man
15. Four year's treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia
16. Dextromethorphan for the treatment of neuropathic pain: A double blind randomized controlled trial with integral n-of-1 design
17. High dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia
18. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties
19. Therapeutic brain concentration of the NMDA receptor antagonist amantadine
20. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?
21. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: A double blind, randomized, placebo controlled trial